CD4 and neoplasm: Thus, activation of these cells could be an effective anti-tumor immunotherapy, which has been proven by clinical observation showing that high levels of CD8+ and CD4+ T cells are associated with improved survival in breast (30), head and neck (31), colon (32), and lung cancer (33).